News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

US Delays Approval for Discovery Laboratories (DSCO)' Surfaxin


5/2/2008 6:25:11 AM

NEW YORK, May 2 (Reuters) - The U.S. Food and Drug Administration declined to immediately approve Discovery Laboratories Inc's drug to help prevent respiratory distress syndrome in premature babies, the company said on Friday, sending shares down 41 percent.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES